About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalJapan
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
1,501
By Phase
PHASE2/PHASE3: 1PHASE2: 1
By Status
COMPLETED: 4SUSPENDED: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05407389Lead Sponsor
Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study
PHASE2/PHASE3Suspended
600 participants
Started: Apr 21, 2022 · Completed: Mar 31, 2026
NCT04913272Lead Sponsor
Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV
PHASE2Suspended
630 participants
Started: Jun 24, 2021 · Completed: Dec 31, 2025
NCT01450657Lead Sponsor
Observational Study of Kibow Biotics in Chronic Kidney Failure Patients
N/ACompleted
31 participants
Started: Jul 31, 2011 · Completed: Oct 31, 2012
NCT01450670Lead Sponsor
Observational Study of Kibow Biotics in Dialysis Patients
N/ACompleted
30 participants
Started: May 31, 2011 · Completed: Jul 31, 2012
NCT01450709Lead Sponsor
Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis
N/ACompleted
30 participants
Started: Apr 30, 2011 · Completed: Oct 31, 2012
Locations (1)
Headquarters
Tokyo, Japan
Map
Loading map...